Regular surveillance of IL-23A levels, particularly in those with a familial background or other predisposing factors for GAD, might facilitate early detection and prompt therapies, potentially halting the development of clinically significant anxiety. This evidence concerns the gene IL23A and generalized anxiety disorder.